APA (7th ed.) Citation

S, X., Y, H., J, Y., L, W., H, L., C, Y., . . . J, Y. (2026). Salvianolic acid a inhibits neuroinflammation and ameliorates Alzheimer's disease pathology via the p38 MAPK/NF-κB pathway based on network pharmacology and experimental validation. International immunopharmacology, 178, 116594. https://doi.org/10.1016/j.intimp.2026.116594

Chicago Style (17th ed.) Citation

S, Xiao, Han Y, Yan J, Wu L, Lin H, Yuan C, Song C, and Ye J. "Salvianolic Acid a Inhibits Neuroinflammation and Ameliorates Alzheimer's Disease Pathology via the P38 MAPK/NF-κB Pathway Based on Network Pharmacology and Experimental Validation." International Immunopharmacology 178 (2026): 116594. https://doi.org/10.1016/j.intimp.2026.116594.

MLA (9th ed.) Citation

S, Xiao, et al. "Salvianolic Acid a Inhibits Neuroinflammation and Ameliorates Alzheimer's Disease Pathology via the P38 MAPK/NF-κB Pathway Based on Network Pharmacology and Experimental Validation." International Immunopharmacology, vol. 178, 2026, p. 116594, https://doi.org/10.1016/j.intimp.2026.116594.